Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,56 USD | -1,71% | +1,56% | -29,12% |
15/04 | VERACYTE, INC. : Goldman Sachs nog altijd een koopadvies | ZM |
26/02 | VERACYTE, INC. : Morgan Stanley geeft een verkoopadvies | ZM |
Vakgebied
Aantal werknemers: 815
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Diagnostic Products and Biopharmaceutical Services
100,0
%
| 297 | 100,0 % | 361 | 100,0 % | +21,76% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
92,7
%
| 263 | 88,7 % | 335 | 92,7 % | +27,23% |
International
7,3
%
| 34 | 11,3 % | 27 | 7,3 % | -21,08% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marc Stapley
CEO | Chief Executive Officer | 54 | 01-06-21 |
Rebecca Chambers
DFI | Director of Finance/CFO | 46 | 19-07-21 |
Steven French
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-22 |
Phillip Febbo
CTO | Chief Tech/Sci/R&D Officer | 57 | 02-10-23 |
Richard T. Kloos
CTO | Chief Tech/Sci/R&D Officer | - | 05-04-12 |
Shayla Gorman
IRC | Investor Relations Contact | - | 01-02-22 |
Tracy Morris
IRO | Public Communications Contact | - | - |
John Leite
PRN | Corporate Officer/Principal | - | 01-09-22 |
Annie McGuire
HRO | Human Resources Officer | 44 | 28-02-22 |
Robert Brainin
PRN | Corporate Officer/Principal | 53 | 08-07-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Evan Jones
BRD | Director/Board Member | 67 | 01-02-08 |
Robert Epstein
CHM | Chairman | 69 | 12-01-15 |
Karin Eastham
BRD | Director/Board Member | 74 | 01-12-12 |
John Bishop
BRD | Director/Board Member | 79 | 01-12-14 |
Jens Holstein
BRD | Director/Board Member | 60 | 01-08-20 |
Marc Stapley
CEO | Chief Executive Officer | 54 | 01-06-21 |
Eliav Barr
BRD | Director/Board Member | - | 09-08-22 |
Muna Bhanji
BRD | Director/Board Member | 61 | 19-03-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 78 436 369 | 77 537 934 ( 98,85 %) | 0 | 98,85 % |
Bedrijfsgegevens
Veracyte, Inc.
6000 Shoreline Court Suite 300
94080, South San Francisco
+650 243 6300
http://www.veracyte.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-29,12% | 1,49 mld. | |
-19,98% | 11,48 mld. | |
+40,71% | 3,27 mld. | |
-36,97% | 2,2 mld. | |
-18,92% | 2,05 mld. | |
+13,51% | 1,01 mld. | |
-4,37% | 743 mln. | |
-36,75% | 413 mln. | |
-48,47% | 377 mln. | |
+16,90% | 374 mln. |
- Beurs
- Aandelen
- Koers VCYT
- Onderneming Veracyte, Inc.